Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Vietnam Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Vietnam Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Vietnam
- Number of Pages: 74
Executive Summary 5
Vietnam Pharmaceutical And Healthcare Industry SWOT .... 6
Vietnam Political SWOT . 7
Vietnam Economics SWOT ........ 7
Vietnam Business Environment SWOT............. 8
Vietnam – Business Environment Rankings .......... 9
Table: Asia Pacific Pharmaceutical Business Environment Ratings ........ 9
Limits Of Potential Returns........ 9
Risks To Realisation Of Returns ... 10
Market Summary .........11
Regulatory Regime 12
Pharmaceutical Advertising..... 12
Intellectual Property Environment 13
IP Shortcomings ............ 13
Counterfeit Drugs ......... 14
Other Regulatory Issues 15
Pricing And Reimbursement Regime.............. 16
Price Increases ............. 17
Recent Pricing Developments .. 18
Industry Trends And Developments .20
Epidemiology ................ 20
Healthcare Sector ......... 22
Healthcare Insurance ... 23
Healthcare And Pharmaceutical Reforms...... 24
Foreign Partnerships .... 25
Domestic Pharmaceutical Sector .. 25
Retail Sector 27
Key Aspects Of Good Pharmacy Practice (GPP) In Developing Countries ...... 28
Foreign Pharmaceutical Sector .... 29
Traditional Medicines ... 29
Research And Development ..... 30
Table Clinical Trial Considerations In Asia .. 31
Vaccine Sector .............. 31
Biotechnology Sector .... 32
Medical Device Sector .. 33
Table: Vietnam’s Medical Device Market Data And Forecasts (US$mn unless otherwise stated) ................ 35
Industry Forecast Scenario 36
Overall Market Forecast.......... 36
Table: Vietnam - Drug Expenditure And Prescription Market Indicators (US$mn unless otherwise stated) 37
Key Growth Factors – Industry 39
Table: Vietnam’s Health Expenditure Data And Forecast, 2006-2012 .. 40
Key Growth Factors – Macroeconomic ......... 41
Table: Vietnam - Economic Activity............... 43
Patented Market Forecast........ 44
Table: Vietnam’s Patented Drugs Market Data And Forecasts (US$mn unless otherwise stated) ................ 45
Generic Market Forecasts ....... 46
Table: Vietnam’s Generics Market Data And Forecasts, 2006-2012 ..... 47
OTC Market Forecast ... 48
Table: OTC Market Data Forecasts (US$mn unless otherwise stated) .. 49
Export/Import Forecasts.......... 50
Export/Import Forecasts.......... 50
Table: Vietnam’s Pharmaceutical Trade Data And Forecasts (US$mn) 51
Other Healthcare Data Forecasts . 52
Table: Other Health Indicators 52
Key Risks To BMI’s Forecast Scenario.......... 53
Competitive Landscape ........54
Company Profiles .........55
Leading Multinational Manufacturers ................ 55
Pfizer ...... 55
GlaxoSmithKline ........... 56
Sanofi-Aventis ............... 58
Novartis .. 60
Merck & Co . 61
Indigenous Manufacturer Profiles 62
Vietnam Pharmaceutical Corporation (Vinapharm)............ 62
Vietnam OPV Pharmaceutical Co . 64
Stada Vietnam ............... 65
Vietnam Pharmaceutical Joint Stock Company (Ampharco) 67
Vidipha Central Pharmaceutical Joint Stock Company ....... 69
BMI Forecast Modelling ........70
How We Generate Our Pharmaceutical Industry Forecasts ..... 70
Pharmaceutical Industry.......... 71
Pharmaceutical Business Environment Ratings Methodology .. 71
Ratings Overview .......... 71
Table: Pharmaceutical Business Environment Indicators ... 72
Weighting 73
Table: Weighting Of Components . 73
Sources ........ 73
Vietnam Pharmaceutical And Healthcare Industry SWOT .... 6
Vietnam Political SWOT . 7
Vietnam Economics SWOT ........ 7
Vietnam Business Environment SWOT............. 8
Vietnam – Business Environment Rankings .......... 9
Table: Asia Pacific Pharmaceutical Business Environment Ratings ........ 9
Limits Of Potential Returns........ 9
Risks To Realisation Of Returns ... 10
Market Summary .........11
Regulatory Regime 12
Pharmaceutical Advertising..... 12
Intellectual Property Environment 13
IP Shortcomings ............ 13
Counterfeit Drugs ......... 14
Other Regulatory Issues 15
Pricing And Reimbursement Regime.............. 16
Price Increases ............. 17
Recent Pricing Developments .. 18
Industry Trends And Developments .20
Epidemiology ................ 20
Healthcare Sector ......... 22
Healthcare Insurance ... 23
Healthcare And Pharmaceutical Reforms...... 24
Foreign Partnerships .... 25
Domestic Pharmaceutical Sector .. 25
Retail Sector 27
Key Aspects Of Good Pharmacy Practice (GPP) In Developing Countries ...... 28
Foreign Pharmaceutical Sector .... 29
Traditional Medicines ... 29
Research And Development ..... 30
Table Clinical Trial Considerations In Asia .. 31
Vaccine Sector .............. 31
Biotechnology Sector .... 32
Medical Device Sector .. 33
Table: Vietnam’s Medical Device Market Data And Forecasts (US$mn unless otherwise stated) ................ 35
Industry Forecast Scenario 36
Overall Market Forecast.......... 36
Table: Vietnam - Drug Expenditure And Prescription Market Indicators (US$mn unless otherwise stated) 37
Key Growth Factors – Industry 39
Table: Vietnam’s Health Expenditure Data And Forecast, 2006-2012 .. 40
Key Growth Factors – Macroeconomic ......... 41
Table: Vietnam - Economic Activity............... 43
Patented Market Forecast........ 44
Table: Vietnam’s Patented Drugs Market Data And Forecasts (US$mn unless otherwise stated) ................ 45
Generic Market Forecasts ....... 46
Table: Vietnam’s Generics Market Data And Forecasts, 2006-2012 ..... 47
OTC Market Forecast ... 48
Table: OTC Market Data Forecasts (US$mn unless otherwise stated) .. 49
Export/Import Forecasts.......... 50
Export/Import Forecasts.......... 50
Table: Vietnam’s Pharmaceutical Trade Data And Forecasts (US$mn) 51
Other Healthcare Data Forecasts . 52
Table: Other Health Indicators 52
Key Risks To BMI’s Forecast Scenario.......... 53
Competitive Landscape ........54
Company Profiles .........55
Leading Multinational Manufacturers ................ 55
Pfizer ...... 55
GlaxoSmithKline ........... 56
Sanofi-Aventis ............... 58
Novartis .. 60
Merck & Co . 61
Indigenous Manufacturer Profiles 62
Vietnam Pharmaceutical Corporation (Vinapharm)............ 62
Vietnam OPV Pharmaceutical Co . 64
Stada Vietnam ............... 65
Vietnam Pharmaceutical Joint Stock Company (Ampharco) 67
Vidipha Central Pharmaceutical Joint Stock Company ....... 69
BMI Forecast Modelling ........70
How We Generate Our Pharmaceutical Industry Forecasts ..... 70
Pharmaceutical Industry.......... 71
Pharmaceutical Business Environment Ratings Methodology .. 71
Ratings Overview .......... 71
Table: Pharmaceutical Business Environment Indicators ... 72
Weighting 73
Table: Weighting Of Components . 73
Sources ........ 73
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
